Non-invasive prenatal testing, commonly called NIPT, is a blood test that screens for certain chromosomal conditions during pregnancy. It analyzes small fragments of DNA from the placenta circulating in the pregnant patient’s bloodstream, often referred to as cell-free DNA. Because it only requires a standard blood draw, NIPT carries none of the miscarriage risk associated with diagnostic procedures like amniocentesis or chorionic villus sampling (CVS).
NIPT is a screening test, not a diagnostic test. That means it estimates the likelihood of a condition rather than confirming one. If results suggest a higher chance of a chromosomal difference, your provider will typically recommend follow-up testing. As part of a broader genetic screening plan, NIPT helps give you and your care team a clearer picture early in pregnancy.
How NIPT Works
During pregnancy, DNA fragments from the placenta enter the mother’s bloodstream. Since the placenta and fetus usually share the same genetic makeup, analyzing this DNA can provide insight into the baby’s chromosomes.
NIPT evaluates whether there is more or less genetic material than expected from specific chromosomes. If the amounts are outside the typical range, it may suggest an increased chance of a chromosomal condition.
The test is generally performed after 10 weeks of pregnancy, when enough cell-free DNA is present in the blood for accurate results. Results typically come back within one to two weeks, though timing can vary by lab.
What NIPT Screens For
NIPT most commonly screens for conditions caused by extra or missing chromosomes, including:
- Trisomy 21 (Down syndrome)
- Trisomy 18 (Edwards syndrome)
- Trisomy 13 (Patau syndrome)
Some versions of the test also screen for sex chromosome differences, such as Turner syndrome or Klinefelter syndrome. Expanded panels that look for specific microdeletions are available, but these may have different accuracy profiles and are not always recommended.
What NIPT Does Not Do
NIPT does not provide a complete picture of every possible genetic or structural condition. It does not replace anatomy ultrasounds, carrier screening for inherited conditions, or diagnostic testing when those are needed. It is one tool within a broader prenatal care plan, and many patients benefit from combining it with ultrasound and routine monitoring.
Who Should Consider NIPT?
NIPT is available to many pregnant patients and is often offered as part of early prenatal screening.
